STOCK TITAN

[Form 4] TFS Financial Corporation Insider Trading Activity

Filing Impact
(Moderate)
Filing Sentiment
(Negative)
Form Type
4
Rhea-AI Filing Summary

TFS Financial Corporation director and CFO Meredith S. Weil sold 15,000 shares on 09/02/2025 at $13.70 per share, reducing her direct holdings to 63,527 shares (held with shared voting power with spouse). The filing details multiple equity awards and derivative holdings: 19,170 performance stock units that will vest and distribute on 12/10/2025; a series of restricted stock units totaling 34,934 shares with staged vesting dates; and employee stock options covering 266,100 shares with exercise prices of $14.74, $19.31, and $19.06 and varying exercisable/expiration schedules. Some plan-held shares are held indirectly via a 401(k) and ESOP.

Il direttore e CFO di TFS Financial Corporation, Meredith S. Weil, ha venduto 15.000 azioni il 02/09/2025 a $13,70 per azione, riducendo la sua partecipazione diretta a 63.527 azioni (con diritto di voto condiviso con il coniuge). La comunicazione elenca inoltre vari incentivi azionari e strumenti derivati: 19.170 performance stock unit che matureranno e saranno distribuite il 10/12/2025; una serie di restricted stock unit per un totale di 34.934 azioni con date di maturazione scaglionate; e opzioni su azioni per i dipendenti su 266.100 azioni con prezzi di esercizio di $14,74, $19,31 e $19,06 e scadenze/esercitabilità differenziate. Alcune azioni del piano sono detenute indirettamente tramite un 401(k) e un ESOP.

La directora y CFO de TFS Financial Corporation, Meredith S. Weil, vendió 15.000 acciones el 02/09/2025 a $13,70 por acción, reduciendo su participación directa a 63.527 acciones (con poder de voto compartido con su cónyuge). El informe detalla además varias compensaciones en acciones y posiciones derivadas: 19.170 unidades de acciones por desempeño que vencerán y se distribuirán el 10/12/2025; una serie de unidades restringidas por un total de 34.934 acciones con fechas de adquisición escalonadas; y opciones sobre acciones para empleados por 266.100 acciones con precios de ejercicio de $14,74, $19,31 y $19,06 y distintos calendarios de ejercicio/expiración. Algunas acciones del plan se mantienen indirectamente a través de un 401(k) y un ESOP.

TFS Financial Corporation의 이사 겸 최고재무책임자(CFO) Meredith S. Weil은 2025년 9월 2일 주당 $13.70에 15,000주를 매각하여 직접 보유 지분을 63,527주(배우자와 공동 의결권 보유)로 줄였습니다. 제출 서류에는 다수의 지분 보상 및 파생 보유가 상세히 기재되어 있습니다: 2025년 12월 10일에 성과주 단위 19,170주가 확정·지급될 예정이며; 단계별 권리확정 일정을 가진 제한주 단위 총 34,934주; 그리고 행사가 $14.74, $19.31, $19.06인 직원 스톡옵션 총 266,100주가 서로 다른 행사·만기 일정으로 포함되어 있습니다. 일부 플랜 보유 주식은 401(k)와 ESOP을 통해 간접 보유됩니다.

Meredith S. Weil, administratrice et CFO de TFS Financial Corporation, a vendu 15 000 actions le 02/09/2025 au prix de 13,70 $ par action, réduisant ses participations directes à 63 527 actions (pouvoir de vote partagé avec son conjoint). Le dépôt détaille également plusieurs attributions en actions et positions dérivées : 19 170 unités d'actions de performance qui seront acquises et distribuées le 10/12/2025 ; une série d'unités d'actions restreintes totalisant 34 934 actions avec des dates d'acquisition échelonnées ; et des options d'achat d'actions pour les employés portant sur 266 100 actions avec des prix d'exercice de 14,74 $, 19,31 $ et 19,06 $ et des calendriers d'exercice/expiration variables. Certaines actions détenues dans le cadre du plan sont détenues indirectement via un 401(k) et un ESOP.

Meredith S. Weil, Direktorin und CFO der TFS Financial Corporation, verkaufte am 02.09.2025 15.000 Aktien zum Preis von $13,70 pro Aktie und verringerte damit ihre direkten Beteiligungen auf 63.527 Aktien (Stimmrechte werden mit dem Ehepartner geteilt). Die Meldung beschreibt zudem mehrere Aktienvergütungen und derivative Bestände: 19.170 Performance-Stock-Units, die am 10.12.2025 fällig werden und ausgezahlt werden; eine Reihe von Restricted Stock Units insgesamt 34.934 Aktien mit gestaffelten Vesting-Terminen; sowie Mitarbeiteraktienoptionen über 266.100 Aktien mit Ausübungspreisen von $14,74, $19,31 und $19,06 und unterschiedlichen Ausübungs-/Ablaufplänen. Einige plangehaltene Aktien werden indirekt über einen 401(k) und einen ESOP gehalten.

Positive
  • Reporting person retains significant equity exposure through 266,100 stock options and 34,934 restricted/performance units representing potential future alignment with shareholders
  • Performance stock units of 19,170 will vest and distribute on 12/10/2025, providing deferred compensation linked to past performance
  • Some shares held indirectly via 401(k) and ESOP, indicating additional long-term ownership mechanisms
Negative
  • Sale of 15,000 shares on 09/02/2025 at $13.70 reduced direct holdings to 63,527 shares
  • Portion of holdings are exercisable options with exercise prices above and below current sale price, which may result in future dilution if exercised

Insights

TL;DR: Insider sale of 15,000 shares modestly reduces direct ownership but substantial vested and unvested equity positions remain.

The reported sale on 09/02/2025 at $13.70 for 15,000 shares lowers direct beneficial ownership to 63,527 shares while the reporting person retains large option and RSU/PSU positions totaling over 280,000 underlying shares. The presence of multiple long-dated option grants and PSUs that vest in 2025-2028 suggests continued alignment with shareholder value over time. This filing discloses both immediate liquidity via the sale and sustained compensation exposure to future stock performance.

TL;DR: Transaction is a routine insider sale amid ongoing compensation awards and standard vesting schedules.

The Form 4 indicates the reporting person is both a director and CFO and that some shares are held with shared voting power with a spouse. Numerous equity awards and staged vesting (including dividend-equivalent entitlements on PSUs and RSUs) are documented, consistent with standard executive compensation practices. The filing includes a Section 16 disclosure of the sale and comprehensive grant histories, fulfilling reporting obligations.

Il direttore e CFO di TFS Financial Corporation, Meredith S. Weil, ha venduto 15.000 azioni il 02/09/2025 a $13,70 per azione, riducendo la sua partecipazione diretta a 63.527 azioni (con diritto di voto condiviso con il coniuge). La comunicazione elenca inoltre vari incentivi azionari e strumenti derivati: 19.170 performance stock unit che matureranno e saranno distribuite il 10/12/2025; una serie di restricted stock unit per un totale di 34.934 azioni con date di maturazione scaglionate; e opzioni su azioni per i dipendenti su 266.100 azioni con prezzi di esercizio di $14,74, $19,31 e $19,06 e scadenze/esercitabilità differenziate. Alcune azioni del piano sono detenute indirettamente tramite un 401(k) e un ESOP.

La directora y CFO de TFS Financial Corporation, Meredith S. Weil, vendió 15.000 acciones el 02/09/2025 a $13,70 por acción, reduciendo su participación directa a 63.527 acciones (con poder de voto compartido con su cónyuge). El informe detalla además varias compensaciones en acciones y posiciones derivadas: 19.170 unidades de acciones por desempeño que vencerán y se distribuirán el 10/12/2025; una serie de unidades restringidas por un total de 34.934 acciones con fechas de adquisición escalonadas; y opciones sobre acciones para empleados por 266.100 acciones con precios de ejercicio de $14,74, $19,31 y $19,06 y distintos calendarios de ejercicio/expiración. Algunas acciones del plan se mantienen indirectamente a través de un 401(k) y un ESOP.

TFS Financial Corporation의 이사 겸 최고재무책임자(CFO) Meredith S. Weil은 2025년 9월 2일 주당 $13.70에 15,000주를 매각하여 직접 보유 지분을 63,527주(배우자와 공동 의결권 보유)로 줄였습니다. 제출 서류에는 다수의 지분 보상 및 파생 보유가 상세히 기재되어 있습니다: 2025년 12월 10일에 성과주 단위 19,170주가 확정·지급될 예정이며; 단계별 권리확정 일정을 가진 제한주 단위 총 34,934주; 그리고 행사가 $14.74, $19.31, $19.06인 직원 스톡옵션 총 266,100주가 서로 다른 행사·만기 일정으로 포함되어 있습니다. 일부 플랜 보유 주식은 401(k)와 ESOP을 통해 간접 보유됩니다.

Meredith S. Weil, administratrice et CFO de TFS Financial Corporation, a vendu 15 000 actions le 02/09/2025 au prix de 13,70 $ par action, réduisant ses participations directes à 63 527 actions (pouvoir de vote partagé avec son conjoint). Le dépôt détaille également plusieurs attributions en actions et positions dérivées : 19 170 unités d'actions de performance qui seront acquises et distribuées le 10/12/2025 ; une série d'unités d'actions restreintes totalisant 34 934 actions avec des dates d'acquisition échelonnées ; et des options d'achat d'actions pour les employés portant sur 266 100 actions avec des prix d'exercice de 14,74 $, 19,31 $ et 19,06 $ et des calendriers d'exercice/expiration variables. Certaines actions détenues dans le cadre du plan sont détenues indirectement via un 401(k) et un ESOP.

Meredith S. Weil, Direktorin und CFO der TFS Financial Corporation, verkaufte am 02.09.2025 15.000 Aktien zum Preis von $13,70 pro Aktie und verringerte damit ihre direkten Beteiligungen auf 63.527 Aktien (Stimmrechte werden mit dem Ehepartner geteilt). Die Meldung beschreibt zudem mehrere Aktienvergütungen und derivative Bestände: 19.170 Performance-Stock-Units, die am 10.12.2025 fällig werden und ausgezahlt werden; eine Reihe von Restricted Stock Units insgesamt 34.934 Aktien mit gestaffelten Vesting-Terminen; sowie Mitarbeiteraktienoptionen über 266.100 Aktien mit Ausübungspreisen von $14,74, $19,31 und $19,06 und unterschiedlichen Ausübungs-/Ablaufplänen. Einige plangehaltene Aktien werden indirekt über einen 401(k) und einen ESOP gehalten.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
WEIL MEREDITH S

(Last) (First) (Middle)
7007 BROADWAY AVENUE

(Street)
CLEVELAND OH 44105

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
TFS Financial CORP [ TFSL ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Financial Officer
3. Date of Earliest Transaction (Month/Day/Year)
09/02/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 09/02/2025 S 15,000 D $13.7 63,527 D(1)
Common Stock 364 I By 401(k)(2)
Common Stock 538 I BY ESOP(2)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Performance Restricted Share Units (3) (4) (4) Common Stock 19,170 19,170 D
Restricted Stock Units (3) (5) (5) Common Stock 16,600 16,600 D
Restricted Stock Units (3) (6) (6) Common Stock 9,600 9,600 D
Restricted Stock Units (3) (7) (7) Common Stock 4,734 4,734 D
Restricted Stock Units (3) (8) (8) Common Stock 3,600 3,600 D
Employee Stock Option (right to buy) $14.74 (9) 01/05/2028 Common Stock 187,500 187,500 D
Employee Stock Option (right to buy) $19.31 (10) 12/15/2026 Common Stock 54,400 54,400 D
Employee Stock Option (right to buy) $19.06 (11) 12/17/2025 Common Stock 24,200 24,200 D
Explanation of Responses:
1. Shares are held with shared voting power with spouse.
2. Reflects transactions not required to be reported under Section 16 of the Securities Exchange Act, as amended.
3. Each restricted and performance stock unit represents a contingent right to receive one share of TFS Financial Corporation common stock. Restricted and performance stock units are entitled to dividend equivalent rights in the form of a cash payment in the amount of any cash dividend paid per share of common stock.
4. On November 21, 2024, the reporting person achieved performance level of 90.0% on a target award of 21,300 Performance Share Units ("PSUs"), resulting in a total earned award of 19,170 shares. This represents the final determination a December 15, 2022 award that was dependent on certain performance results during the two fiscal year period ended September 30, 2024. Each PSU represents a contingent right to receive one share of TFS Financial Corporation common stock and are entitled to dividend equivalent rights in the form of a cash payment in the amount of any cash dividend paid per share of common stock during the period the award was outstanding. The shares and dividend equivalent payment will vest and distribute to the reporting person on December 10, 2025.
5. On December 19, 2024, the reporting person received a grant of 16,600 Restricted Stock Units (RSUs). These RSUs vest in three equal annual installments beginning December 10, 2025.
6. On March 4, 2024, the reporting person received a grant of 14,400 Restricted Stock Units (RSUs). These RSUs vest in three equal annual installments beginning December 10, 2024.
7. On December 15, 2022, the reporting person received a grant of 14,200 Restricted Stock Units (RSUs). These RSUs vest in three equal installments beginning December 10, 2023
8. As reported on a Form 4 dated September 29, 2011, the reporting person received a grant of 3,600 restricted stock units that vest in four equal annual installments beginning May 14, 2011. Vested shares may be distributed to the Reporting Person only after that person's termination of employment with TFS Financial Corporation.
9. As reported on a Form 4 dated January 8, 2018, the reporting person received a grant of 187,500 stock options. These stock options vest in three equal annual installments beginning December 10, 2018.
10. As reported on a Form 4 dated December 15, 2016, the reporting person received a grant of 79,400 stock options. These stock options vest in three equal annual installments beginning December 10, 2017.
11. As reported on a Form 4 dated December 17, 2015, the reporting person received a grant of 49,200 stock options on December 15, 2015. These stock options vest in three equal annual installments beginning December 10, 2016.
Remarks:
/s/ Susanne N. Miller, Pursuant to Power of Attorney 09/04/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Meredith S. Weil report for TFSL?

The insider sold 15,000 shares on 09/02/2025 at $13.70 per share, reducing direct beneficial ownership to 63,527 shares (held with shared voting power with spouse).

How many performance and restricted units does the reporting person hold for TFSL?

Performance stock units: 19,170 (vesting and distribution on 12/10/2025). Restricted stock units: 34,934 total across multiple grants with staged vesting schedules.

What employee stock options does the reporting person hold in TFSL?

Total options: 266,100 underlying shares across grants with exercise prices of $14.74, $19.31, and $19.06 and varying exercisable/expiration dates (including exercisable beginning 12/10/2018 and through 01/05/2028).

Are any shares held indirectly by the reporting person for TFSL?

Yes. The filing shows 364 shares indirectly held via a 401(k) and 538 shares indirectly held via an ESOP.

When will the 19,170 PSUs vest and distribute for TFSL?

The PSUs will vest and distribute on 12/10/2025.
Tfs Finl Corp

NASDAQ:TFSL

TFSL Rankings

TFSL Latest News

TFSL Latest SEC Filings

TFSL Stock Data

3.82B
279.23M
0.45%
91.91%
1.32%
Banks - Regional
Savings Institution, Federally Chartered
Link
United States
CLEVELAND